Cresud SACIF y A
SWB:CD8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cresud SACIF y A
SWB:CD8
|
AR |
|
S
|
Shashank Traders Ltd
BSE:540221
|
IN |
|
I
|
IncJet Holding Inc
OTC:SORT
|
US |
|
M
|
Mineral Commodities Ltd
F:58M
|
AU |
|
BW LPG Ltd
F:BW9
|
SG |
|
Cryptoblox Technologies Inc
OTC:CRYBF
|
CA |
|
PHX Energy Services Corp
TSX:PHX
|
CA |
|
Gefran SpA
F:GF7
|
IT |
|
A
|
Alten SA
F:AN3
|
FR |
|
S
|
Solucorp Industries Ltd
OTC:SLUP
|
US |
|
A
|
Ave SA
ATHEX:AVE
|
GR |
|
R
|
Rank Group PLC
XMUN:RNKA
|
UK |
|
T
|
Technology General Corp
OTC:TCGN
|
US |
|
I
|
Innovative Medtech Inc
OTC:IMTH
|
US |
Dividends
Dividend Yield
Cresud SACIF y A
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Cresud SACIF y A
Payout Ratio
Cresud SACIF y A
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for CD8 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CD8 Price
Cresud SACIF y A
| Average Annual Return | 39.99% |
| Standard Deviation of Annual Returns | 32.95% |
| Max Drawdown | -45% |
| Market Capitalization | 1T EUR |
| Shares Outstanding | 59 028 800 |
| Percentage of Shares Shorted |
N/A
|
CD8 Return Decomposition
Main factors of price return
Stock Splits
CD8's latest stock split occurred on Nov 28, 2025
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, CD8 traded at 10.1446 per share. Afterward, the share price was about 10.
The adjusted shares began trading on Nov 28, 2025. This was stock split number 8 in CD8's history, following the previous one in Dec 6, 2023.
